Empresa Vertex Pharmaceuticals Incorporated
Acciones
VRTX
US92532F1003
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
418 USD | +0,17 % | +0,55 % | +2,73 % |
Resumen de negocios
Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (61,2%), Europa (31,5%) y otros (7,3%).
Número de empleados: 5 400
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 8 931 | 100,0 % | 9 869 | 100,0 % | +10,51 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
61,2
%
| 5 699 | 63,8 % | 6 040 | 61,2 % | +5,98 % |
Europe
31,5
%
| 2 706 | 30,3 % | 3 109 | 31,5 % | +14,91 % |
Other
7,3
%
| 526 | 5,9 % | 720 | 7,3 % | +36,87 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 01/02/17 | |
Jeffrey Leiden
CHM | Chairman | 68 | 08/07/09 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 10/04/19 |
Mike Tirozzi
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Carmen Bozic
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Stuart Arbuckle
COO | Chief Operating Officer | 58 | 04/09/12 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/16 |
Edward Atkinson
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/07/20 |
David Altshuler
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/15 |
Susie Lisa
IRC | Investor Relations Contact | - | 01/09/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 08/06/17 |
Jeffrey Leiden
CHM | Chairman | 68 | 08/07/09 |
Bruce Sachs
BRD | Director/Board Member | 64 | 01/01/98 |
Director/Board Member | 69 | 17/05/11 | |
Lloyd Carney
BRD | Director/Board Member | 62 | 21/02/19 |
Michel Lagarde
BRD | Director/Board Member | 49 | 05/10/23 |
Sangeeta Bhatia
BRD | Director/Board Member | 55 | 18/06/15 |
Diana McKenzie
BRD | Director/Board Member | 59 | 03/06/20 |
Suketu Upadhyay
BRD | Director/Board Member | 55 | 18/05/22 |
Chief Executive Officer | 51 | 01/02/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 258 307 816 | 258 015 560 ( 99,89 %) | 0 | 99,89 % |
Información de la empresa
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,73 % | 108 mil M | |
+9,59 % | 104 mil M | |
+6,58 % | 23,66 mil M | |
-12,59 % | 22,1 mil M | |
-3,29 % | 19,71 mil M | |
-35,36 % | 18,2 mil M | |
-13,29 % | 16,19 mil M | |
+4,68 % | 13,72 mil M | |
+34,25 % | 12,22 mil M | |
-6,78 % | 10,36 mil M |
- Bolsa
- Acciones
- Acción Vertex Pharmaceuticals Incorporated - Nasdaq
- Empresa Vertex Pharmaceuticals Incorporated